Kelly Jean Fitzgerald, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiotherapy | 2 | 2023 | 1494 | 0.550 |
Why?
|
| Immunotherapy | 2 | 2023 | 4752 | 0.500 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2822 | 0.300 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2023 | 5389 | 0.300 |
Why?
|
| Lung Neoplasms | 4 | 2024 | 13451 | 0.240 |
Why?
|
| Radiosurgery | 2 | 2024 | 1328 | 0.230 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2024 | 140 | 0.210 |
Why?
|
| Radiation Tolerance | 1 | 2023 | 475 | 0.180 |
Why?
|
| Combined Modality Therapy | 2 | 2023 | 8529 | 0.170 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2023 | 451 | 0.150 |
Why?
|
| Radiotherapy Dosage | 1 | 2024 | 2865 | 0.140 |
Why?
|
| Antibodies | 2 | 2016 | 2417 | 0.140 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2024 | 1643 | 0.120 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2016 | 323 | 0.120 |
Why?
|
| Neoplasms | 2 | 2023 | 22340 | 0.120 |
Why?
|
| Pyruvaldehyde | 1 | 2013 | 16 | 0.110 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2013 | 48 | 0.110 |
Why?
|
| Biomimetic Materials | 1 | 2014 | 170 | 0.110 |
Why?
|
| Medical Oncology | 1 | 2023 | 2339 | 0.090 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 3946 | 0.080 |
Why?
|
| Drug Design | 1 | 2014 | 1042 | 0.080 |
Why?
|
| Lung | 1 | 2024 | 10033 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 4893 | 0.060 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2014 | 1883 | 0.050 |
Why?
|
| Organs at Risk | 1 | 2024 | 352 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2023 | 228 | 0.050 |
Why?
|
| Thorax | 1 | 2024 | 554 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 36532 | 0.030 |
Why?
|
| Humans | 10 | 2024 | 765968 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2023 | 2024 | 0.030 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 2014 | 90 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2014 | 2163 | 0.020 |
Why?
|
| Boron Compounds | 1 | 2013 | 196 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 2014 | 559 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2016 | 1947 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2013 | 697 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2024 | 20659 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2014 | 1617 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 2659 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2014 | 1520 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2013 | 3067 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2023 | 6547 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2024 | 8923 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2014 | 3946 | 0.020 |
Why?
|
| Molecular Imaging | 1 | 2013 | 822 | 0.020 |
Why?
|
| Kinetics | 1 | 2013 | 6274 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 9373 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2024 | 81514 | 0.010 |
Why?
|
| Cell Survival | 1 | 2013 | 5747 | 0.010 |
Why?
|
| Algorithms | 1 | 2024 | 14071 | 0.010 |
Why?
|
| Prognosis | 1 | 2023 | 29922 | 0.010 |
Why?
|
| Aged | 2 | 2024 | 171117 | 0.010 |
Why?
|
| Mutation | 1 | 2023 | 30198 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 17075 | 0.010 |
Why?
|
| Male | 2 | 2024 | 363698 | 0.010 |
Why?
|
| Middle Aged | 1 | 2024 | 223009 | 0.010 |
Why?
|
| Female | 1 | 2024 | 396112 | 0.000 |
Why?
|